Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31644
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-03-20T08:13:12Z | - |
dc.date.available | 2023-03-20T08:13:12Z | - |
dc.date.issued | 2003-11 | - |
dc.identifier.citation | Ali, R. vd. (2003). “Successful treatment of acquired haemophilia with prednisolone therapy”. Haemophilia, 9(6), 741-743. | en_US |
dc.identifier.issn | 1351-8216 | - |
dc.identifier.uri | https://doi.org/10.1046/j.1351-8216.2003.00830.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/full/10.1046/j.1351-8216.2003.00830.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/31644 | - |
dc.description.abstract | Acquired hemophilia is a rare, life threatening coagulopathy in adults caused by the development of autoantibodies against to factor VIII. No general consensus exists on the best therapeutic approach. We report here a case that presented with extensive cutaneous and mucosal bleedings due to factor VIII inhibitors and treated successfully with steroid therapy alone but complicated with a life threatening thromboembolic attack during her follow up. In conclusion, corticosteroids are "cost effective therapy" associated with high inhibitor elimination rates and although recurrence of inhibitor in a patient with factor VIII inhibitor is an expected clinical situation thrombosis risk should also be considered. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hematology | en_US |
dc.subject | Acquired inhibitors | en_US |
dc.subject | Acquired hemophilia | en_US |
dc.subject | Factor VIII inhibitors | en_US |
dc.subject | Immunosuppressive therapy | en_US |
dc.title | Successful treatment of acquired haemophilia with prednisolone therapy | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000186752100013 | tr_TR |
dc.identifier.scopus | 2-s2.0-0346957439 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Deri ve Zührevi Hastalıklar Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 741 | tr_TR |
dc.identifier.endpage | 743 | tr_TR |
dc.identifier.volume | 9 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Haemophilia | en_US |
dc.contributor.buuauthor | Ali, Rıdvan | - |
dc.contributor.buuauthor | Özçelik, Tülay | - |
dc.contributor.buuauthor | Özkalemkaş, Fahir | - |
dc.contributor.buuauthor | Özkocaman, Vildan | - |
dc.contributor.buuauthor | Ozan, Ülkü | - |
dc.contributor.buuauthor | Yalçın, M. | - |
dc.contributor.buuauthor | Sarıcaoğlu, Hayriye | - |
dc.contributor.buuauthor | Tunalı, Ahmet | - |
dc.contributor.researcherid | AAH-1854-2021 | tr_TR |
dc.contributor.researcherid | AAG-8495-2021 | tr_TR |
dc.identifier.pubmed | 14750942 | tr_TR |
dc.subject.wos | Hematology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 7201813027 | tr_TR |
dc.contributor.scopusid | 7005424333 | tr_TR |
dc.contributor.scopusid | 6601912387 | tr_TR |
dc.contributor.scopusid | 6603145040 | tr_TR |
dc.contributor.scopusid | 6507254632 | tr_TR |
dc.contributor.scopusid | 7005476035 | tr_TR |
dc.contributor.scopusid | 6603722836 | tr_TR |
dc.contributor.scopusid | 6602797853 | tr_TR |
dc.subject.scopus | Acquired Factor 8 Deficiency; Hemophilia A; Hemorrhage | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Corticosteroid therapy | en_US |
dc.subject.emtree | Cost effectiveness analysis | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Hemophilia | en_US |
dc.subject.emtree | Hemophilia A | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Mucosal bleeding | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Risk assessment | en_US |
dc.subject.emtree | Skin bleeding | en_US |
dc.subject.emtree | Thromboembolism | en_US |
dc.subject.emtree | Thrombosis | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Ampicillin | en_US |
dc.subject.emtree | Autoantibody | en_US |
dc.subject.emtree | Blood clotting factor 8 antibody | en_US |
dc.subject.emtree | Blood clotting factor 8 inhibitor | en_US |
dc.subject.emtree | Corticosteroid | en_US |
dc.subject.emtree | Fresh frozen plasma | en_US |
dc.subject.emtree | Immunosuppressive agent | en_US |
dc.subject.emtree | Indapamide | en_US |
dc.subject.emtree | Perindopril | en_US |
dc.subject.emtree | Prednisolone | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.